Fig. 4From: Rational in silico drug design of HIV-RT inhibitors through G-QSAR and molecular docking study of 4-arylthio and 4-aryloxy-3-iodopyridine-2(1-H)-one derivativea–c Fitness plot between training and test set compounds for model-I, model-II, and model-IIIBack to article page